BioCentury
ARTICLE | Company News

Connetics, Pierre Fabre Group sales and marketing update

October 4, 2004 7:00 AM UTC

CNCT granted Pierre Fabre's Pierre Fabre Dermatologie unit exclusive European commercialization rights to Olux clobetasol propionate, which is approved to treat steroid responsive dermatoses of the s...